Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of Australia

被引:14
作者
Offen, Sophie [1 ,2 ,6 ]
Strange, Geoff [3 ,4 ]
Playford, David [4 ]
Celermajer, David S. [1 ,2 ,3 ]
Stewart, Simon [4 ,5 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia
[2] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Heart Res Inst, Sydney, NSW, Australia
[4] Univ Notre Dame Australia, Fremantle, WA, Australia
[5] Univ Glasgow, Glasgow, Scotland
[6] Royal Prince Alfred Hosp, Dept Cardiol, Missenden Rd, Camperdown, NSW 2050, Australia
关键词
Tricuspid Regurgitation; Cardiac Implantable Electronic Device; Echocardiography; AMERICAN SOCIETY; PACEMAKER; RECOMMENDATIONS; MORTALITY; MECHANISM; LEADS;
D O I
10.1016/j.ijcard.2022.10.160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: We sought to analyse the distribution of TR severity and survival in a large cohort of adults with CIED leads. Methods: The distribution of TR severity was analysed in 18,797 adults (mean age 73.8+/-13.9, 63.3% men) with CIED leads undergoing echocardiography across 25 centres. Survival status and cause of death were linked and the relationship between TR severity and mortality during 2.6 (interquartile range 1.1-4.6) years follow-up examined. Data from 439,558 individuals (mean age 62.1 +/- 17.8 years, 51.5% men) without a CIED were sub-sequently incorporated in a pooled cohort analysis. Results: Overall, 8,824/18,797 individuals (47%) with a CIED had no/trivial TR; 5,490 (29.2%) mild TR; 3,068 (16.3%) moderate TR; and 1,415 (7.5%) severe TR. Moderate or greater TR was independently associated with age, female sex, atrial fibrillation and significant left heart disease (p<0.001 for all). 8,868 individuals (47.2%) died from any cause (43.2% from cardiovascular causes). Individuals with moderate or severe TR had a 1.6 to 2.5-fold increased risk of all-cause mortality in adjusted models, compared to those with no TR (p<0.001 for both). In the pooled cohort analysis, CIEDs were associated with a near 2-fold (95% CI 1.81-1.99; p<0.001) increased probability of moderate or greater TR, on adjusted basis. However, the mortality associated with moderate or greater TR did not differ significantly with respect to the presence or absence of a device lead. Conclusions: Moderate or greater TR is more prevalent in those with CIED's, even in adjusted models, and was independently associated with incremental risks for all-cause and cardiovascular mortality.
引用
收藏
页码:338 / 344
页数:7
相关论文
共 32 条
[1]   Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation [J].
Addetia, Karima ;
Harb, Serge C. ;
Hahn, Rebecca T. ;
Kapadia, Samir ;
Lang, Roberto M. .
JACC-CARDIOVASCULAR IMAGING, 2019, 12 (04) :622-636
[2]   Tricuspid Regurgitation and Implantable Devices [J].
Al-Bawardy, Rasha ;
Krishnaswamy, Amar ;
Rajeswaran, Jeevanantham ;
Bhargava, Mandeep ;
Wazni, Oussama ;
Wilkoff, Bruce ;
Tuzcu, Emin Murat ;
Martin, David ;
Thomas, James ;
Blackstone, Eugene ;
Kapadia, Samir .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02) :259-266
[3]   Prevalence and Mechanism of Tricuspid Regurgitation following Implantation of Endocardial Leads for Pacemaker or Cardioverter-Defibrillator [J].
Al-Mohaissen, Maha A. ;
Chan, Kwan Leung .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2012, 25 (03) :245-252
[4]   Prevalence and Significance of Tricuspid Regurgitation Post-Endocardial Lead Placement [J].
Anvardeen, Kalilur ;
Rao, Rajeev ;
Hazra, Samir ;
Hay, Karen ;
Dai, Hongyan ;
Stoyanov, Nik ;
Birnie, David ;
Dwivedi, Girish ;
Chan, Kwan Leung .
JACC-CARDIOVASCULAR IMAGING, 2019, 12 (03) :562-564
[5]  
BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32
[6]   Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation [J].
Chang, James D. ;
Manning, Warren J. ;
Ebrille, Elisa ;
Zimetbaum, Peter J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (18) :2331-2341
[7]   Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads [J].
Cheng, Yan ;
Gao, Huanhuan ;
Tang, Liyan ;
Li, Jing ;
Yao, Lei .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2016, 33 (11) :1689-1696
[8]   Tricuspid regurgitation and long-term clinical outcomes [J].
Chorin, Ehud ;
Rozenbaum, Zach ;
Topilsky, Yan ;
Konigstein, Maayan ;
Ziv-Baran, Tomer ;
Richert, Eyal ;
Keren, Gad ;
Banai, Shmuel .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2020, 21 (02) :157-165
[9]   Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads [J].
Delling, Francesca N. ;
Hassan, Zena K. ;
Piatkowski, Gail ;
Tsao, Connie W. ;
Rajabali, Alefiyah ;
Markson, Lawrence J. ;
Zimetbaum, Peter J. ;
Manning, Warren J. ;
Chang, James D. ;
Mukamal, Kenneth J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06) :988-992
[10]   Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up [J].
Hoke, Ulas ;
Auger, Dominique ;
Thijssen, Joep ;
Wolterbeek, Ron ;
van der Velde, Enno T. ;
Holman, Eduard R. ;
Schalij, Martin J. ;
Bax, Jeroen J. ;
Delgado, Victoria ;
Marsan, Nina Ajmone .
HEART, 2014, 100 (12) :960-968